Literature DB >> 18841391

Activated Akt as an indicator of prognosis in gastric cancer.

Caterina Cinti1, Carla Vindigni, Alessandra Zamparelli, Dario La Sala, Maria Carmela Epistolato, Daniele Marrelli, Gabriele Cevenini, Piero Tosi.   

Abstract

The immunohistochemical expression of phosphorylated (activated) Akt (pAkt) in 50 advanced gastric carcinomas has been analyzed and the results correlated with age, sex, location in the stomach, histotype, stage, survival, mitotic and apoptotic index, some cell cycle regulators (cyclin D1, cyclin E, p34/cdc2, p27/kip1), and cell proliferation. There was a statistically significant direct correlation between pAkt expression (both cytoplasmatic and nuclear) and depth of infiltration of the tumor, number of infiltrated lymph nodes and p34/cdc2 expression, and between prevalently nuclear pAkt and cyclin D1 and cyclin E. Conversely, there was a significant inverse correlation between nuclear pAkt and apoptotic index and between cytoplasmatic and nuclear pAkt and patient survival. No correlation was found between pAkt and sex, age, tumor location, histotype, mitotic index, and cell proliferation. These findings suggest that pAkt may be considered an indicator of tumor progression and patient survival in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841391     DOI: 10.1007/s00428-008-0676-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  51 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

Authors:  Hemant K Roy; Bola F Olusola; Dahn L Clemens; William J Karolski; Anne Ratashak; Henry T Lynch; Thomas C Smyrk
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

3.  Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.

Authors:  Y Takano; Y Kato; M Masuda; Y Ohshima; I Okayasu
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

4.  Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.

Authors:  Eiji Oki; Hideo Baba; Eriko Tokunaga; Toshihiko Nakamura; Naoyuki Ueda; Motonori Futatsugi; Kohjiro Mashino; Manabu Yamamoto; Masahiko Ikebe; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Cancer       Date:  2005-11-10       Impact factor: 7.396

5.  A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.

Authors:  Byung Lan Lee; Woo Ho Kim; Jieun Jung; Sung Jin Cho; Jong-Wan Park; Jihyen Kim; Hee-Yong Chung; Mee Soo Chang; Seon Young Nam
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

6.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

Review 7.  Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Authors:  Jiyong Liang; Joyce M Slingerland
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

8.  Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma.

Authors:  Nanami Itoh; Shuho Semba; Masafumi Ito; Hiroaki Takeda; Sumio Kawata; Mitsunori Yamakawa
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

9.  Akt1/protein kinase B alpha is involved in gastric cancer progression and cell proliferation.

Authors:  Zheyi Han; Kaichun Wu; Huiqin Shen; Chunying Li; Shuang Han; Liu Hong; Yongquan Shi; Na Liu; Changcun Guo; Yan Xue; Taidong Qiao; Daiming Fan
Journal:  Dig Dis Sci       Date:  2008-04-01       Impact factor: 3.199

10.  Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

Authors:  A Bellacosa; D de Feo; A K Godwin; D W Bell; J Q Cheng; D A Altomare; M Wan; L Dubeau; G Scambia; V Masciullo; G Ferrandina; P Benedetti Panici; S Mancuso; G Neri; J R Testa
Journal:  Int J Cancer       Date:  1995-08-22       Impact factor: 7.396

View more
  34 in total

1.  Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.

Authors:  Jingchao Xu; Li Jia; Hongye Ma; Yanping Li; Zhenhai Ma; Yongfu Zhao
Journal:  Tumour Biol       Date:  2013-12-18

2.  Suppression of breast cancer proliferation and induction of apoptosis via AKT and ERK1/2 signal transduction pathways by synthetic polypeptide derived from viral macrophage inflammatory protein II.

Authors:  Qingling Yang; Changjie Chen; Zhifeng Yang; Yangjun Gao; Jie Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

3.  Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

Authors:  Dongyun Yang; Andrew Hendifar; Cosima Lenz; Kayo Togawa; Felicitas Lenz; Georg Lurje; Alexandra Pohl; Thomas Winder; Yan Ning; Susan Groshen; Heinz-Josef Lenz
Journal:  J Gastrointest Oncol       Date:  2011-06

4.  The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.

Authors:  Oscar Tapia; Ismael Riquelme; Pamela Leal; Alejandra Sandoval; Susana Aedo; Helga Weber; Pablo Letelier; Enrique Bellolio; Miguel Villaseca; Patricia Garcia; Juan Carlos Roa
Journal:  Virchows Arch       Date:  2014-05-21       Impact factor: 4.064

5.  Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line.

Authors:  Hamed Manoochehri Khoshinani; Saeid Afshar; Abdolazim Sedighi Pashaki; Ali Mahdavinezhad; Safora Nikzad; Rezvan Najafi; Razieh Amini; Mohammad Hadi Gholami; Alireza Khoshghadam; Massoud Saidijam
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

6.  The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.

Authors:  Ismael Riquelme; Oscar Tapia; Jaime A Espinoza; Pamela Leal; Kurt Buchegger; Alejandra Sandoval; Carolina Bizama; Juan Carlos Araya; Richard M Peek; Juan Carlos Roa
Journal:  Pathol Oncol Res       Date:  2016-05-07       Impact factor: 3.201

7.  AKT and PTEN expression in human gastrointestinal carcinoid tumors.

Authors:  Susan C Pitt; Ruth Davis; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Am J Transl Res       Date:  2009-02-28       Impact factor: 4.060

8.  Visualization of sphingolipids and phospholipids in the fundic gland mucosa of human stomach using imaging mass spectrometry.

Authors:  Nobuya Kurabe; Hisaki Igarashi; Ippei Ohnishi; Shogo Tajima; Yusuke Inoue; Yoshihiko Takahashi; Mitsutoshi Setou; Haruhiko Sugimura
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

9.  MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN.

Authors:  Zhang Chun-Zhi; Han Lei; Zhang An-Ling; Fu Yan-Chao; Yue Xiao; Wang Guang-Xiu; Jia Zhi-Fan; Pu Pei-Yu; Zhang Qing-Yu; Kang Chun-Sheng
Journal:  BMC Cancer       Date:  2010-07-12       Impact factor: 4.430

10.  Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.

Authors:  Guo-Qing Li; Juan Xie; Xiao-Yong Lei; Li Zhang
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.